UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 99

Sortiert nach

Relationship of PCSK9 and Urinary Thromboxane Excretion to Cardiovascular Events in Patients With Atrial Fibrillation

Journal of the American College of Cardiology, 2017-09, Vol.70 (12), p.1455-1462

2017

Volltextzugriff (PDF)

Incomplete Inhibition of Thromboxane Biosynthesis by Acetylsalicylic Acid : Determinants and Effect on Cardiovascular Risk

Circulation (New York, N.Y.), 2008-10, Vol.118 (17), p.1705-1712

2008

Volltextzugriff (PDF)

Pharmacodynamic effects of indobufen compared with aspirin in patients with coronary atherosclerosis

European journal of clinical pharmacology, 2021-12, Vol.77 (12), p.1815-1823

2021

Volltextzugriff (PDF)

Oxidative damage, platelet activation, and inflammation to predict mobility disability and mortality in older persons: results from the health aging and body composition study

The journals of gerontology. Series A, Biological sciences and medical sciences, 2012-06, Vol.67 (6), p.671-676

2012

Volltextzugriff (PDF)

Association of cyclooxygenase-2 genetic variant with cardiovascular disease

European heart journal, 2014-09, Vol.35 (33), p.2242-2248

2014

Volltextzugriff (PDF)

Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events

Circulation (New York, N.Y.), 2002-04, Vol.105 (14), p.1650-1655

2002

Volltextzugriff (PDF)

Antiplatelet Effect Durability of a Novel, 24-hour, Extended-Release Prescription Formulation of Acetylsalicylic Acid in Patients With Type 2 Diabetes Mellitus

The American journal of cardiology, 2016-12, Vol.118 (12), p.1941-1947

2016

Volltextzugriff (PDF)

Urinary 11-dehydro-thromboxane B2 is associated with cardiovascular events and mortality in patients with atrial fibrillation

The American heart journal, 2015-09, Vol.170 (3), p.490-497.e1

2015

Volltextzugriff (PDF)

Reduced Variability to Aspirin Antiplatelet Effect by the Coadministration of Statins in High‐Risk Patients for Cardiovascular Disease

Clinical pharmacology and therapeutics, 2018-07, Vol.104 (1), p.111-119

2018

Volltextzugriff (PDF)

Aging‐Related Decline of Glutathione Peroxidase 3 and Risk of Cardiovascular Events in Patients With Atrial Fibrillation

Journal of the American Heart Association, 2016-09, Vol.5 (9), p.n/a

2016

Volltextzugriff (PDF)

Anti Xa oral anticoagulants inhibit in vivo platelet activation by modulating glycoprotein VI shedding

Pharmacological research, 2016-11, Vol.113 (Pt A), p.484-489

2016

Volltextzugriff (PDF)

Mediterranean diet reduces thromboxane A2 production in atrial fibrillation patients

Clinical nutrition (Edinburgh, Scotland), 2015-10, Vol.34 (5), p.899-903

2015

Volltextzugriff (PDF)

Effects of high-amount-high-intensity exercise on in vivo platelet activation: modulation by lipid peroxidation and AGE/RAGE axis

Thrombosis and haemostasis, 2013-12, Vol.110 (6), p.1232

2013

Volltextzugriff (PDF)

Circulating Dickkopf‐1 in Diabetes Mellitus: Association With Platelet Activation and Effects of Improved Metabolic Control and Low‐Dose Aspirin

Journal of the American Heart Association, 2014-07, Vol.3 (4), p.n/a

2014

Volltextzugriff (PDF)

Relation of Fish Oil Supplementation to Markers of Atherothrombotic Risk in Patients With Cardiovascular Disease Not Receiving Lipid-Lowering Therapy

The American journal of cardiology, 2015-05, Vol.115 (9), p.1204-1211

2015

Volltextzugriff (PDF)

Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus

Journal of thrombosis and haemostasis, 2010-04, Vol.8 (4), p.828-837

2010

Volltextzugriff (PDF)

Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids

The Journal of pharmacology and experimental therapeutics, 1999-05, Vol.289 (2), p.735

1999

Volltextzugriff (PDF)

Urinary 11‐Dehydro‐Thromboxane B2 as a Predictor of Acute Myocardial Infarction Outcomes: Results of Leukotrienes and Thromboxane In Myocardial Infarction (LTIMI) Study

Journal of the American Heart Association, 2016-08, Vol.5 (8), p.n/a

2016

Volltextzugriff (PDF)

11-dehydro thromboxane B2 levels after percutaneous transluminal angioplasty in patients with peripheral arterial occlusive disease during a one year follow-up period

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2016-06, Vol.67 (3), p.377

2016

Volltextzugriff (PDF)

Statin Therapy and Inflammation in Patients with Diabetes Treated with High Dose Aspirin

Journal of diabetes and its complications, 2016-09, Vol.30 (7), p.1365-1370

2016

Volltextzugriff (PDF)

Aspirin resistance detected with aggregometry cannot be explained by cyclooxygenase activity: involvement of other signaling pathway(s) in cardiovascular events of aspirin‐treated patients

Journal of thrombosis and haemostasis, 2006-06, Vol.4 (6), p.1271-1278

2006

Volltextzugriff (PDF)

Celecoxib, ibuprofen, and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart disease

Clinical pharmacology and therapeutics, 2006-09, Vol.80 (3), p.264-274

2006

Volltextzugriff (PDF)

Thromboxane-Dependent CD40 Ligand Release in Type 2 Diabetes Mellitus

Journal of the American College of Cardiology, 2006-01, Vol.47 (2), p.391-397

2006

Volltextzugriff (PDF)

Determinants of thromboxane biosynthesis in patients with moderate to severe chronic kidney disease

European journal of internal medicine, 2016-09, Vol.33, p.74-80

2016

Volltextzugriff (PDF)

Comparison between urinary 11-dehydrothromboxane B2 detection and platelet Light Transmission Aggregometry (LTA) assays for evaluating aspirin response in elderly patients with coronary artery disease

Gene, 2015-10, Vol.571 (1), p.23-27

2015

Volltextzugriff (PDF)

1 – 25 von 99

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect_期刊（NSTL购买）

Zeitschrift / SerieThrombosis Research

ThemaAdult

ThemaAged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(94)
Mit Volltextzugriff
(84)

Publikationsform

Artikel
(99)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(99)
Male
(96)
Female
(93)
Middle Aged
(82)
Thromboxane B2 - Analogs & Derivatives
(81)
Thromboxane B2 - Urine
(78)
Science & Technology
(77)
Life Sciences & Biomedicine
(76)
Cardiovascular System & Cardiology
(42)
Biological And Medical Sciences
(39)
Medical Sciences
(38)
Cardiac & Cardiovascular Systems
(27)
Aspirin - Therapeutic Use
(26)
Thromboxane B2 - Blood
(25)
Aspirin
(22)
Peripheral Vascular Disease
(21)
Platelet Aggregation Inhibitors - Therapeutic Use
(21)
Platelet Aggregation - Drug Effects
(19)
Risk Factors
(19)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Relationship of PCSK9 and Urinary Thromboxane Excretion to Cardiovascular Events in Patients With Atrial Fibrillation

Incomplete Inhibition of Thromboxane Biosynthesis by Acetylsalicylic Acid : Determinants and Effect on Cardiovascular Risk

Pharmacodynamic effects of indobufen compared with aspirin in patients with coronary atherosclerosis

Oxidative damage, platelet activation, and inflammation to predict mobility disability and mortality in older persons: results from the health aging and body composition study

Association of cyclooxygenase-2 genetic variant with cardiovascular disease

Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events

Antiplatelet Effect Durability of a Novel, 24-hour, Extended-Release Prescription Formulation of Acetylsalicylic Acid in Patients With Type 2 Diabetes Mellitus

Urinary 11-dehydro-thromboxane B2 is associated with cardiovascular events and mortality in patients with atrial fibrillation

Reduced Variability to Aspirin Antiplatelet Effect by the Coadministration of Statins in High‐Risk Patients for Cardiovascular Disease

Aging‐Related Decline of Glutathione Peroxidase 3 and Risk of Cardiovascular Events in Patients With Atrial Fibrillation

Anti Xa oral anticoagulants inhibit in vivo platelet activation by modulating glycoprotein VI shedding

Mediterranean diet reduces thromboxane A2 production in atrial fibrillation patients

Effects of high-amount-high-intensity exercise on in vivo platelet activation: modulation by lipid peroxidation and AGE/RAGE axis

Circulating Dickkopf‐1 in Diabetes Mellitus: Association With Platelet Activation and Effects of Improved Metabolic Control and Low‐Dose Aspirin

Relation of Fish Oil Supplementation to Markers of Atherothrombotic Risk in Patients With Cardiovascular Disease Not Receiving Lipid-Lowering Therapy

Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus

Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids

Urinary 11‐Dehydro‐Thromboxane B2 as a Predictor of Acute Myocardial Infarction Outcomes: Results of Leukotrienes and Thromboxane In Myocardial Infarction (LTIMI) Study

11-dehydro thromboxane B2 levels after percutaneous transluminal angioplasty in patients with peripheral arterial occlusive disease during a one year follow-up period

Statin Therapy and Inflammation in Patients with Diabetes Treated with High Dose Aspirin

Aspirin resistance detected with aggregometry cannot be explained by cyclooxygenase activity: involvement of other signaling pathway(s) in cardiovascular events of aspirin‐treated patients

Celecoxib, ibuprofen, and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart disease

Thromboxane-Dependent CD40 Ligand Release in Type 2 Diabetes Mellitus

Determinants of thromboxane biosynthesis in patients with moderate to severe chronic kidney disease

Comparison between urinary 11-dehydrothromboxane B2 detection and platelet Light Transmission Aggregometry (LTA) assays for evaluating aspirin response in elderly patients with coronary artery disease

Aktive Filter

Suchergebnisse filtern